These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14952426)

  • 21. [Relation between heparin in repeated doses & intensity of the clearing. effect in healthy & arteriosclerotic subjects; potentiation of this effect in atherosclerotics by gastric mucin].
    ROSSI B; RULLI V
    Gazz Med Ital; 1959 May; 118(5):202-4. PubMed ID: 13664059
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of oral heparin in the treatment and prevention of arteriosclerosis].
    ALBRIEUX AS; ROCCA FF; ESTEFAN JC
    Dia Med; 1957 Jan; 29(1):26-8. PubMed ID: 13414560
    [No Abstract]   [Full Text] [Related]  

  • 23. [Heparin treatment of arteriosclerosis].
    KELLER R
    Medizinische; 1954 Jul; 29-30():995-8. PubMed ID: 13185034
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical aspects of the hypocholesterolemic and clearing action of a heparinoid and its relation to atherosclerosis].
    ALMAFARA ML; ORLANDO MM
    Sem Med; 1962 Mar; 120():433-6. PubMed ID: 13860649
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experiences with the administration of heparin in patients with cerebral arteriosclerosis].
    KECOVA H
    Cas Lek Cesk; 1957 Feb; 96(7):193-8. PubMed ID: 13413918
    [No Abstract]   [Full Text] [Related]  

  • 26. [Perlingual heparin therapy of atheroma].
    MONGIN M; FREDENUCCI M
    Mars Med; 1959; 96(3):157-67. PubMed ID: 13655923
    [No Abstract]   [Full Text] [Related]  

  • 27. [ALPHA-2-LIPO-HAPTOGLOBULIN AND SIDEROPHILIN IN ATHEROSCLEROSIS].
    ROMERO RL; CATINO AA; SCAGLIA HE; MALJAR L; VIVES C
    Rev Clin Esp; 1964 Dec; 95():363-9. PubMed ID: 14270785
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of hypertension with heparin].
    CHIARI M; STEMBERGER T
    Wien Klin Wochenschr; 1957 Nov; 69(45):854-6. PubMed ID: 13530977
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antiatheromatous properties of heparin: objective clinical and biological].
    TAMCHES A
    Presse Med (1893); 1953 Oct; 61(68):1382. PubMed ID: 13112166
    [No Abstract]   [Full Text] [Related]  

  • 30. [Small doses of intra-arterial heparin in therapy of some peripheral arterial diseases].
    BUTTO M; MASETTO I
    Acta Med Patav; 1954; 14(2):281-92. PubMed ID: 13217714
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mechanism of action of certain drugs used in diabetic arteritis (sodium chloride, heparin)].
    PAVEL I; CEAUSI G; MIHALACHE N; PAVEL D
    Med Interna (Bucur); 1957 Sep; 9(9):1397-413. PubMed ID: 13516029
    [No Abstract]   [Full Text] [Related]  

  • 32. Heparin: pharmacological potentials from atherosclerosis to asthma.
    Ragazzi E; Chinellato A
    Gen Pharmacol; 1995 Jul; 26(4):697-701. PubMed ID: 7635244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of multiple injections of heparin on the hyperlipemia of atherosclerosis. Preliminary report.
    WOLDOW A; LOPEZ RH; GOLDBERG H
    J Albert Einstein Med Cent (Phila); 1962 Apr; 10():68-72. PubMed ID: 14007910
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sublingual administration of heparinlipocaic].
    LABORIT H; DELGA J; BAYLON H; HUGONOT R; DECHEN J
    Presse Med (1893); 1954 Jan; 62(5):79-81. PubMed ID: 13145530
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of bee royal jelly (gelée royale) and of heparin on experimental atherosclerosis of rabbits].
    Madar J; Malý E; Neubauer E; Nicák A; Zapatická J; Kocis J
    Z Alternsforsch; 1965 Sep; 18(2):109-14. PubMed ID: 5875417
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lipoprotein studies on the etiology of arteriosclerosis; with a special reference to paper electrophoretic lipoprotein determination and heparin therapy].
    THURNHERR A; NIEDERBERGER W
    Bull Schweiz Akad Med Wiss; 1956 Apr; 12(1):1-20; discussion, 21-2. PubMed ID: 13316344
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experimentation on a preparation with antisclerogenous action].
    PARIGI A
    Minerva Med; 1959 Feb; 50(15):536-41. PubMed ID: 13643889
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes of cholesterol, choline and protein fractions of blood in atherosclerosis during salt-free diet therapy].
    ANISIMOV VE; ZAITSEV VM
    Sov Med; 1957 Nov; 21(11):95-8. PubMed ID: 13529295
    [No Abstract]   [Full Text] [Related]  

  • 39. [HEPARIN, LIPOPROTEIN LIPASE AND BLOOD FIBRINOLYTIC ACTIVITY IN PATIENTS WITH ATHEROSCLEROSIS DURING IODINE PREPARATION TREATMENT].
    DZIZINSKII AA
    Ter Arkh; 1964 Aug; 36():58-62. PubMed ID: 14251670
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of nicotinic acid on blood coagulation, blood heparin content and clearing factor in patients with atherosclerosis].
    GERASIMOVA IL
    Kardiologiia; 1963; 3():61-4. PubMed ID: 13947300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.